Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
about
Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice.Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.Methylglyoxal attenuates insulin signaling and downregulates the enzymes involved in cholesterol biosynthesis.
P2860
Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
@en
type
label
Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
@en
prefLabel
Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
@en
P2093
P2860
P356
P1476
Reducing methylglyoxal as a therapeutic target for diabetic heart disease.
@en
P2093
Branka Vulesevic
Erik J Suuronen
Ross W Milne
P2860
P304
P356
10.1042/BST20130254
P577
2014-04-01T00:00:00Z